Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-01-22

Clinical Trial Update: Pilot Study to Assess the Effect of a Postbiotic Blend on Moderate Self-reported Anxiety [NA]

View source ↗

Summary

ADM sponsored a pilot trial to evaluate whether a postbiotic blend can affect moderate self-reported anxiety. The trial status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Postbiotic blend

Snippet

Sponsor: The Archer-Daniels-Midland Company | Conditions: Anxiety | NA | Status: COMPLETED